Aeterna Wealth
Balanced Advantage · Regular plan · Growth

WhiteOak Capital Balanced Advantage Fund (Regular)

WhiteOak Capital Mutual Fund · benchmark: 50% Nifty 50 TRI + 50% bond funds · 3.7 years old · AMFI code 151268

Tax: Taxed as an equity fund: gains on units held over a year at 12.5% beyond ₹1.25 lakh a year; within a year, 20%.

A
Track-record rating: 8 of 30 in Balanced Advantage

A (top 30%), score 67.9 out of 100. Describes the past, not a forecast.

Returns against the index

PeriodFundIndex (TRI)DifferenceRank in category
6 months4.9%3.5%+1.4%6 / 37
1 year3.3%1.8%+1.6%14 / 36
3 years (a year)10.8%8.6%+2.3%6 / 30
5 years (a year)––––

Growth option, point to point to 6 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.

Risk

Volatility, 3Y8.8%
Up capture, 3Y123
Down capture, 3Y120
Information ratio, 3Y0.73
Jensen's alpha, 3Y+2.0%
Beta, 3Y1.18
Sharpe, 3Y0.49

Portfolio

Holdings for this scheme are not available yet; its rating uses the track record only.

Common questions

What is the NAV of WhiteOak Capital Balanced Advantage Fund (Regular plan)?

₹15.04 on 6 Nov 2026 (Growth option).

What is the expense ratio of WhiteOak Capital Balanced Advantage Fund (Regular)?

2.23% a year; the Direct plan's is 0.82%.

What return has WhiteOak Capital Balanced Advantage Fund given over 3 years?

10.8% a year (Regular plan) over the 3 years to 6 Nov 2026, against 8.6% for its composite benchmark (50% Nifty 50 TRI + 50% bond funds).

How is WhiteOak Capital Balanced Advantage Fund taxed?

Taxed as an equity fund: gains on units held over a year at 12.5% beyond ₹1.25 lakh a year; within a year, 20%.

How is WhiteOak Capital Balanced Advantage Fund rated?

A: 8 of 30 Regular plans in Balanced Advantage, on its track record. This describes the past and is not a recommendation.

Data as of 8 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from WhiteOak Capital Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.